Hemispherx Biopharma buy melinda
Start price
18.08.10
/
50%
€231.79
Target price
18.02.11
€462.00
Performance (%)
-20.05%
End price
18.02.11
€185.33
Summary
This prediction ended on 18.02.11 with a price of €185.33. The prediction for Hemispherx Biopharma disappointed with a performance of -20.05%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hemispherx Biopharma | - | - | - | - |
| iShares Core DAX® | -2.680% | 4.261% | 2.121% | 57.510% |
| iShares Nasdaq 100 | 0.725% | 5.796% | 34.204% | 92.829% |
| iShares Nikkei 225® | -0.725% | 9.319% | 61.298% | 80.340% |
| iShares S&P 500 | 1.166% | 5.479% | 24.751% | 70.967% |
Comments by melinda for this prediction
In the thread Hemispherx Biopharma diskutieren
Biopharma-
hemispherix Biopharma verkündete seine Schlacht gewonnen sechs Jahren südafrikanischen Investoren, dass sie gewonnen haben
(Laufzeit überschritten)
Stopped prediction by melinda for Hemispherx Biopharma
Hemispherx Biopharma
Start price
Target price
Perf. (%)
€20.02
18.05.17
18.05.17
€26.40
26.05.17
26.05.17
5.27%
26.05.17
26.05.17
